Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ing-Kit Lee, Yi-Ping Sng, Wei-Feng Li, Chao-Long Chen, Chih-Chi Wang, Chih-Che Lin & I-Ling Chen. (2022) Importance of daptomycin dosage on the clinical outcome in liver transplant recipients with vancomycin-resistant enterococci infection. Journal of Chemotherapy 34:6, pages 367-374.
Read now
Read now
Ben Burrowes, David R Harper, Joseph Anderson, Malcolm McConville & Mark C Enright. (2011) Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. Expert Review of Anti-infective Therapy 9:9, pages 775-785.
Read now
Read now
Mazen S. Bader, John Hawboldt & Annie Brooks. (2010) Management of Complicated Urinary Tract Infections in the Era of Antimicrobial Resistance. Postgraduate Medicine 122:6, pages 7-15.
Read now
Read now
Articles from other publishers (38)
Szu-Ting Huang, Jia-Ling Yang, Chi-Ying Lin, Sung-Hsi Huang, Jann-Tay Wang, Yu-Chung Chuang, Yee-Chun Chen & Shan-Chwen Chang. (2023) Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infection. International Journal of Infectious Diseases 129, pages 96-102.
Crossref
Crossref
Tai-Chung Tseng, Yu-Chung Chuang, Jia-Ling Yang, Chi-Ying Lin, Sung-Hsi Huang, Jann-Tay Wang, Yee-Chun Chen & Shan-Chwen Chang. (2023) The Combination of Daptomycin with Fosfomycin is More Effective than Daptomycin Alone in Reducing Mortality of Vancomycin-Resistant Enterococcal Bloodstream Infections: A Retrospective, Comparative Cohort Study. Infectious Diseases and Therapy 12:2, pages 589-606.
Crossref
Crossref
Yu-Chung Chuang, Jann-Tay Wang, Jia-Ling Yang, Chi-Ying Lin, Sung-Hsi Huang, Yee-Chun Chen & Shan-Chwen Chang. (2022) The combination of daptomycin with β-lactam antibiotics is more effective than daptomycin alone for vancomycin-resistant Enterococcus faecium bloodstream infection. Journal of Infection and Public Health 15:12, pages 1396-1402.
Crossref
Crossref
Abdur Rafey, Summiya Nizamuddin, Waleed Qureshi, Ali Anjum & Azra Parveen. (2022) Trends of Vancomycin-Resistant Enterococcus Infections in Cancer Patients. Cureus.
Crossref
Crossref
Yu-Chung Chuang, Hsin-Yi Lin, Jann-Tay Wang, Jia-Ling Yang, Chi-Ying Lin, Sung-Hsi Huang, Yee-Chun Chen & Shan-Chwen Chang. (2022) Daptomycin area under the curve to minimum inhibitory concentration ratio by broth microdilution for predicting the outcome of vancomycin-resistant Enterococcus bloodstream infection. Biomedicine & Pharmacotherapy 155, pages 113710.
Crossref
Crossref
Jann-Tay Wang, Chia-Jui Yang, Jia-Ling Yang, Shu-Wen Lin, Yu-Chung Chuang, Wang-Huei Sheng, Yee-Chun Chen & Shan-Chwen Chang. (2022) A High Daptomycin Dose Is Associated with Better Bacterial Clearance in Infections Caused by Vancomycin-Resistant Enterococcus faecium Regardless of Daptomycin Minimum Inhibitory Concentration in a Rat Infective Endocarditis Model. Microbiology Spectrum 10:5.
Crossref
Crossref
Shivani Gargvanshi & William G. Gutheil. (2022) Library Screening for Synergistic Combinations of FDA-Approved Drugs and Metabolites with Vancomycin against VanA-Type Vancomycin-Resistant Enterococcus faecium. Microbiology Spectrum 10:5.
Crossref
Crossref
Catarina Geraldes, Luís Tavares, Solange Gil & Manuela Oliveira. (2022) Enterococcus Virulence and Resistant Traits Associated with Its Permanence in the Hospital Environment. Antibiotics 11:7, pages 857.
Crossref
Crossref
Masoud Dadashi, Parastoo Sharifian, Nazila Bostanshirin, Bahareh Hajikhani, Narjess Bostanghadiri, Nafiseh Khosravi-Dehaghi, Alex van Belkum & Davood Darban-Sarokhalil. (2021) The Global Prevalence of Daptomycin, Tigecycline, and Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Strains From Human Clinical Samples: A Systematic Review and Meta-Analysis. Frontiers in Medicine 8.
Crossref
Crossref
Shivani Gargvanshi, Harika Vemula & William G. Gutheil. (2021)
Effect of Vancomycin on Cytoplasmic Peptidoglycan Intermediates and
van
Operon mRNA Levels in VanA-Type Vancomycin-Resistant Enterococcus faecium
. Journal of Bacteriology 203:16.
Crossref
Crossref
Aishat A. F. Manga S. B. I. O. Obaroh. Bioku R. J. Abdulkadir B.. (2021) An Overview on the Application of Bacteriophage Therapy in Combating Antibiotics Resistance: A Review. UMYU Journal of Microbiology Research (UJMR) 6:1, pages 113-119.
Crossref
Crossref
Iain J. Abbott, Elke van Gorp, Aart van der Meijden, Rixt A. Wijma, Joseph Meletiadis, Jason A. Roberts, Johan W. Mouton & Anton Y. Peleg. (2020)
Oral Fosfomycin Treatment for Enterococcal Urinary Tract Infections in a Dynamic
In Vitro
Model
. Antimicrobial Agents and Chemotherapy 64:6.
Crossref
Crossref
Anoma Nellore & Shirish Huprikar. (2019)
Vancomycin‐resistant
Enterococcus
in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
. Clinical Transplantation 33:9.
Crossref
Crossref
Yu-Chung ChuangHsin-Yi LinPao-Yu ChenChi-Ying LinYee-Chun ChenJann-Tay WangShan-Chwen Chang. (2018) Survival of Patients With Vancomycin-Resistant Enterococcus faecium Bacteremia Treated With Conventional or High Doses of Daptomycin or Linezolid Is Associated With the Rate of Bacterial Clearance*. Critical Care Medicine 46:10, pages 1634-1642.
Crossref
Crossref
Ruru Bi, Tingting Qin, Wenting Fan, Ping Ma & Bing Gu. (2018) The emerging problem of linezolid-resistant enterococci. Journal of Global Antimicrobial Resistance 13, pages 11-19.
Crossref
Crossref
Yu-Chung Chuang, Pao-Yu Chen, Chi-Ying Lin, Yee-Chun Chen, Jann-Tay Wang & Shan-Chwen Chang. (2018) A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections. Scientific Reports 8:1.
Crossref
Crossref
Yu-Chung ChuangHsin-Yi Lin, Pao-Yu Chen, Chi-Ying Lin, Jann-Tay Wang, Yee-Chun ChenShan-Chwen Chang. (2017) Effect of Daptomycin Dose on the Outcome of Vancomycin-Resistant, Daptomycin-Susceptible Enterococcus faecium Bacteremia. Clinical Infectious Diseases 64:8, pages 1026-1034.
Crossref
Crossref
Y.-C. Chuang, H.-Y. Lin, P.-Y. Chen, C.-Y. Lin, J.-T. Wang & S.-C. Chang. (2016) Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose. Clinical Microbiology and Infection 22:10, pages 890.e1-890.e7.
Crossref
Crossref
Liam TonerNathan PapaSani H. AliyuHarveer DevNathan LawrentschukSamih Al-Hayek. (2016) Vancomycin resistant enterococci in urine cultures: Antibiotic susceptibility trends over a decade at a tertiary hospital in the United Kingdom. Investigative and Clinical Urology 57:2, pages 129.
Crossref
Crossref
Olachi Anuforom, Graham R. Wallace & Laura V. Piddock. (2014) The immune response and antibacterial therapy. Medical Microbiology and Immunology 204:2, pages 151-159.
Crossref
Crossref
Yasutaka Nakamura, Norihiro Sakurai, Koichi Yamada, Sadao Tokimasa, Takeshi Nishikawa, Haruo Shintaku, Katsuya Nagayama & Hiroshi Kakeya. (2015) Investigation of Linezolid Administration to Pediatric Patients with Febrile Neutropenia. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 41:12, pages 894-899.
Crossref
Crossref
Yu-Chung Chuang, Jann-Tay Wang, Hsin-Yi Lin & Shan-Chwen Chang. (2014) Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis. BMC Infectious Diseases 14:1.
Crossref
Crossref
Helio S. Sader, David J. Farrell, Robert K. Flamm & Ronald N. Jones. (2014) Variation in Potency and Spectrum of Tigecycline Activity against Bacterial Strains from U.S. Medical Centers since Its Approval for Clinical Use (2006 to 2012). Antimicrobial Agents and Chemotherapy 58:4, pages 2274-2280.
Crossref
Crossref
Hung-Jen Tang, Chi-Chung Chen, Chun-Cheng Zhang, Bo-An Su, Chien-Ming Li, Tzu-Chieh Weng, Shyh-Ren Chiang, Wen-Chien Ko & Yin-Ching Chuang. (2013) In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates. Diagnostic Microbiology and Infectious Disease 77:3, pages 254-257.
Crossref
Crossref
Sandeep Putty, Harika Vemula, Sudheer Bobba & William G. Gutheil. (2013) A liquid chromatography–tandem mass spectrometry assay for d-Ala-d-Lac: A key intermediate for vancomycin resistance in vancomycin-resistant enterococci. Analytical Biochemistry 442:2, pages 166-171.
Crossref
Crossref
Jason M Pogue, Dror Marchaim, Odaliz Abreu-Lanfranco, Bharath Sunkara, Ryan P Mynatt, Jing J Zhao, Suchitha Bheemreddy, Kayoko Hayakawa, Emily T Martin, Sorabh Dhar, Keith S Kaye & Paul R Lephart. (2013) Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008–10. The Journal of Antibiotics 66:10, pages 625-627.
Crossref
Crossref
Cheol-In Kang. (2013) What’s New in the Management of Bacterial Infections in the Era of Multidrug-Resistant Bacteria?. Korean Journal of Transplantation 27:3, pages 81-86.
Crossref
Crossref
Iyo Takemura-Uchiyama, Jumpei Uchiyama, Miho Satoh, Takako Ujihara, Masanori Daibata & Shigenobu Matsuzaki. (2012) Synergistic bacteriolysis by bacteriophage ϕEF24C endolysin ORF9 and lantibiotic nisin and its application to pulsed-field gel electrophoretic analysis of Enterococcus faecalis. Annals of Microbiology 63:3, pages 1209-1211.
Crossref
Crossref
Kunal Kumar, Divya Awasthi, Seung-Yub Lee, Jason E. Cummings, Susan E. Knudson, Richard A. Slayden & Iwao Ojima. (2013) Benzimidazole-based antibacterial agents against Francisella tularensis. Bioorganic & Medicinal Chemistry 21:11, pages 3318-3326.
Crossref
Crossref
Mai Otsuka, Mohamed A. Kharfan-Dabaja, Gene A. Wetzstein, Rod E. Quilitz, Ramon L. Sandin & John N. Greene. (2012) Daptomycin Therapy for Vancomycin-Resistant Enterococcus Bacteremia in Neutropenic Patients With Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients. Infectious Diseases in Clinical Practice 20:5, pages 319-325.
Crossref
Crossref
Hsih-Yeh Tsai, Chun-Hsing Liao, Yen-Hsu Chen, Po-Liang Lu, Cheng-Hua Huang, Chin-Te Lu, Yin-Ching Chuang, Shih-Ming Tsao, Yao-Shen Chen, Yung-Ching Liu, Wei-Yu Chen, Tsrang-Neng Jang, Hsiu-Chen Lin, Chih-Ming Chen, Zhi-Yuan Shi, Sung-Ching Pan, Jia-Ling Yang, Hsiang-Chi Kung, Chun-Eng Liu, Yu-Jen Cheng, Jien-Wei Liu, Wu Sun, Lih-Shinn Wang, Wen-Chien Ko, Kwok-Woon Yu, Ping-Cherng Chiang, Ming-Hsun Lee, Chun-Ming Lee, Gwo-Jong Hsu & Po-Ren Hsueh. (2012)
Trends in Susceptibility of Vancomycin-Resistant Enterococcus faecium to Tigecycline, Daptomycin, and Linezolid and Molecular Epidemiology of the Isolates: Results from the Tigecycline
In Vitro
Surveillance in Taiwan (TIST) Study, 2006 to 2010
. Antimicrobial Agents and Chemotherapy 56:6, pages 3402-3405.
Crossref
Crossref
Efthimia Tasina, Anna-Bettina Haidich, Stamatia Kokkali & Malamatenia Arvanitidou. (2011) Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis. The Lancet Infectious Diseases 11:11, pages 834-844.
Crossref
Crossref
Ching-Lan Lu, Chia-Ying Liu, Yu-Tsung Huang, Chun-Hsing Liao, Lee-Jene Teng, John D. Turnidge & Po-Ren Hsueh. (2011) Antimicrobial Susceptibilities of Commonly Encountered Bacterial Isolates to Fosfomycin Determined by Agar Dilution and Disk Diffusion Methods. Antimicrobial Agents and Chemotherapy 55:9, pages 4295-4301.
Crossref
Crossref
Po-Ren Hsueh, Daryl J. Hoban, Yehuda Carmeli, Shey-Ying Chen, Sunita Desikan, Marissa Alejandria, Wen-Chien Ko & Tran Quang Binh. (2011) Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. Journal of Infection 63:2, pages 114-123.
Crossref
Crossref
Mingming Ma & Dennis Bong. (2010) Directed Peptide Assembly at the Lipid−Water Interface Cooperatively Enhances Membrane Binding and Activity. Langmuir 27:4, pages 1480-1486.
Crossref
Crossref
Maria Moschovi, Georgios Trimis, Maria Tsotra, Fotini Chatzi, Kalliopi Karamolegou, Antina Santou, Natalia Tourkantoni & George Chrousos. (2010) Efficacy and safety of linezolid in immunocompromised children with cancer. Pediatrics International 52:5, pages 694-698.
Crossref
Crossref
Karen K. Kinney. (2010) Treatment of Infections Caused By Antimicrobial-Resistant Gram-Positive Bacteria. The American Journal of the Medical Sciences 340:3, pages 209-217.
Crossref
Crossref
Francisco Soriano. 2010. Antibiotic and Chemotherapy. Antibiotic and Chemotherapy
334
336
.